Literature DB >> 25870091

Clinical utility of circulating tumor cells in metastatic breast cancer.

Francois-Clement Bidard1, Jean-Yves Pierga2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25870091     DOI： 10.1200/JCO.2014.57.9714

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

Review 1.  Circulating tumor cells: clinical validity and utility.

Authors:  Luc Cabel; Charlotte Proudhon; Hugo Gortais; Delphine Loirat; Florence Coussy; Jean-Yves Pierga; François-Clément Bidard
Journal:  Int J Clin Oncol       Date:  2017-02-25       Impact factor: 3.402

Review 2.  Clinical utility of circulating tumor cells: an update.

Authors:  Antoine Vasseur; Nicolas Kiavue; François-Clément Bidard; Jean-Yves Pierga; Luc Cabel
Journal:  Mol Oncol       Date:  2020-12-25       Impact factor: 6.603

3.  Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.

Authors:  Emanuela Fina; Andrea Necchi; Stefano Bottelli; Carolina Reduzzi; Sara Pizzamiglio; Chiara Iacona; Maria Grazia Daidone; Paolo Verderio; Vera Cappelletti
Journal:  Dis Markers       Date:  2017-02-22       Impact factor: 3.434

4.  Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.

Authors:  Iole Cordone; Serena Masi; Valentina Summa; Mariantonia Carosi; Antonello Vidiri; Alessandra Fabi; Alessia Pasquale; Laura Conti; Immacolata Rosito; Carmine Maria Carapella; Veronica Villani; Andrea Pace
Journal:  Breast Cancer Res       Date:  2017-04-11       Impact factor: 6.466

Review 5.  Tumour biomarkers-Tracing the molecular function and clinical implication.

Authors:  Jiahao Lin; Lie Ma; Di Zhang; Jiafeng Gao; Yipeng Jin; Zhihai Han; Degui Lin
Journal:  Cell Prolif       Date:  2019-03-14       Impact factor: 6.831

Review 6.  CTCs 2020: Great Expectations or Unreasonable Dreams.

Authors:  Elisabetta Rossi; Francesco Fabbri
Journal:  Cells       Date:  2019-08-27       Impact factor: 6.600

7.  Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062).

Authors:  Krishnansu S Tewari; Michael W Sill; Bradley J Monk; Richard T Penson; David H Moore; Heather A Lankes; Lois M Ramondetta; Lisa M Landrum; Leslie M Randall; Ana Oaknin; Mario M Leitao; Eric L Eisenhauer; Paul DiSilvestro; Linda Van Le; Michael L Pearl; James J Burke; Ritu Salani; Debra L Richardson; Helen E Michael; David W Kindelberger; Michael J Birrer
Journal:  Mol Cancer Ther       Date:  2020-08-26       Impact factor: 6.261

8.  HER2 expression identifies dynamic functional states within circulating breast cancer cells.

Authors:  Nicole Vincent Jordan; Aditya Bardia; Ben S Wittner; Cyril Benes; Matteo Ligorio; Yu Zheng; Min Yu; Tilak K Sundaresan; Joseph A Licausi; Rushil Desai; Ryan M O'Keefe; Richard Y Ebright; Myriam Boukhali; Srinjoy Sil; Maristela L Onozato; Anthony J Iafrate; Ravi Kapur; Dennis Sgroi; David T Ting; Mehmet Toner; Sridhar Ramaswamy; Wilhelm Haas; Shyamala Maheswaran; Daniel A Haber
Journal:  Nature       Date:  2016-08-24       Impact factor: 49.962

Review 9.  Circulating tumor cells in breast cancer.

Authors:  Francois-Clement Bidard; Charlotte Proudhon; Jean-Yves Pierga
Journal:  Mol Oncol       Date:  2016-01-12       Impact factor: 6.603
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.